Chico, Ana http://orcid.org/0000-0001-6498-3411
Moreno-Fernández, Jesús http://orcid.org/0000-0002-9703-1094
Fernández-García, Diego http://orcid.org/0000-0003-0437-2867
Solá, Eva http://orcid.org/0000-0003-2721-6920
Article History
Received: 23 August 2023
Accepted: 4 October 2023
First Online: 20 October 2023
Declarations
:
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.
: Ana Chico has received support to attend congresses and courses from Roche, Lilly, MSD, Esteve, Abbott, Sanofi, Abbott, Boehringer, Novalab, Air Liquide, Novo Nordisk and Dexcom; has participated in Advisory Boards from Abbott, Lilly, Sanofi, Novo Nordisk and Air Liquide and has received research support form Roche, Novo Nordisk, Abbott and Dexcom. Jesús Moreno-Fernández reports consultant fees and speaker honoraria from Medtronic, Tandem, Dexcom, Abbott, Roche and Ypsomed. Diego Fernández-García has received consultant fees and speaker honoraria from Tandem, Dexcom, Abbott and Roche. Eva Solá has received support from Novalab, Dexcom, Medtronic, Lilly, Boehringer, Novo Nordisk, Astra Zeneca, Sanofi and Abbott.